Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 2
1957 1
1959 4
1960 9
1961 7
1962 1
1963 2
1966 1
1967 2
1969 3
1972 1
1982 1
1989 1
1990 2
1992 4
1993 4
1994 4
1995 5
1996 5
1997 6
1998 1
1999 8
2000 4
2001 1
2002 2
2003 2
2004 1
2005 1
2006 2
2007 5
2008 7
2009 5
2010 4
2011 4
2012 4
2013 3
2014 9
2015 9
2016 9
2017 16
2018 15
2019 12
2020 11
2021 10
2022 5
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Results by year

Filters applied: . Clear all
Page 1
Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.
Molina JM, Charreau I, Chidiac C, Pialoux G, Cua E, Delaugerre C, Capitant C, Rojas-Castro D, Fonsart J, Bercot B, Bébéar C, Cotte L, Robineau O, Raffi F, Charbonneau P, Aslan A, Chas J, Niedbalski L, Spire B, Sagaon-Teyssier L, Carette D, Mestre SL, Doré V, Meyer L; ANRS IPERGAY Study Group. Molina JM, et al. Among authors: cotte l. Lancet Infect Dis. 2018 Mar;18(3):308-317. doi: 10.1016/S1473-3099(17)30725-9. Epub 2017 Dec 8. Lancet Infect Dis. 2018. PMID: 29229440 Clinical Trial.
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F, Pintado C, Chidiac C, Chas J, Charbonneau P, Delaugerre C, Suzan-Monti M, Loze B, Fonsart J, Peytavin G, Cheret A, Timsit J, Girard G, Lorente N, Préau M, Rooney JF, Wainberg MA, Thompson D, Rozenbaum W, Doré V, Marchand L, Simon MC, Etien N, Aboulker JP, Meyer L, Delfraissy JF; ANRS IPERGAY Study Group. Molina JM, et al. Among authors: cotte l. N Engl J Med. 2015 Dec 3;373(23):2237-46. doi: 10.1056/NEJMoa1506273. Epub 2015 Dec 1. N Engl J Med. 2015. PMID: 26624850 Free article. Clinical Trial.
The road to hepatitis C virus elimination.
Cotte L, Pradat P. Cotte L, et al. Lancet Public Health. 2023 Apr;8(4):e254. doi: 10.1016/S2468-2667(23)00052-X. Lancet Public Health. 2023. PMID: 36965979 Free article. No abstract available.
Dasatinib-induced acute hepatitis.
Bonvin A, Mesnil A, Nicolini FE, Cotte L, Michallet M, Descotes J, Vial T. Bonvin A, et al. Among authors: cotte l. Leuk Lymphoma. 2008 Aug;49(8):1630-2. doi: 10.1080/10428190802136384. Leuk Lymphoma. 2008. PMID: 18608866 No abstract available.
Reply.
Cotte L, Rabodonirina M. Cotte L, et al. J Infect Dis. 2000 Jul;182(1):381. doi: 10.1086/315665. J Infect Dis. 2000. PMID: 10882636 No abstract available.
Pulmonary manifestations of leptospirosis.
Paganin F, Bourdin A, Borgherini G, Dalban C, Poubeau P, Tixier F, Gouix A, Noel JB, Cotte L, Arvin-Berod C. Paganin F, et al. Among authors: cotte l. Rev Mal Respir. 2011 Nov;28(9):e131-9. doi: 10.1016/j.rmr.2011.09.024. Epub 2011 Oct 27. Rev Mal Respir. 2011. PMID: 22123152 Free article.
Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure Prophylaxis.
Gantner P, Hessamfar M, Souala MF, Valin N, Simon A, Ajana F, Bouvet E, Rouveix E, Cotte L, Bani-Sadr F, Hustache-Mathieu L, Lebrette MG, Truchetet F, Galempoix JM, Piroth L, Pellissier G, Muret P, Rey D; E/C/F/TAF PEP Study Group. Gantner P, et al. Among authors: cotte l. Clin Infect Dis. 2020 Feb 14;70(5):943-946. doi: 10.1093/cid/ciz577. Clin Infect Dis. 2020. PMID: 31804669 Clinical Trial.
208 results